KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Change in Taxes: 2013-2022

Historic Change in Taxes for Travere Therapeutics (TVTX) over the last 3 years, with Dec 2022 value amounting to -$22,000.

  • Travere Therapeutics' Change in Taxes rose 76.34% to -$22,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $154,000, marking a year-over-year increase of 100.90%. This contributed to the annual value of $41,000 for FY2024, which is 17.14% up from last year.
  • According to the latest figures from Q4 2022, Travere Therapeutics' Change in Taxes is -$22,000, which was down 108.33% from $264,000 recorded in Q3 2022.
  • Travere Therapeutics' 5-year Change in Taxes high stood at $18.8 million for Q1 2020, and its period low was -$16.8 million during Q2 2021.
  • Its 3-year average for Change in Taxes is -$111,100, with a median of -$48,000 in 2020.
  • In the last 5 years, Travere Therapeutics' Change in Taxes soared by 6,280.26% in 2020 and then plummeted by 22,566.22% in 2021.
  • Quarterly analysis of 4 years shows Travere Therapeutics' Change in Taxes stood at -$555,000 in 2019, then surged by 735.32% to $3.5 million in 2020, then tumbled by 102.64% to -$93,000 in 2021, then skyrocketed by 76.34% to -$22,000 in 2022.
  • Its last three reported values are -$22,000 in Q4 2022, $264,000 for Q3 2022, and -$93,000 during Q4 2021.